Director/PDMR Shareholding

Summary by AI ^BETAClose X

Primary Health Properties PLC has notified the market of a nil cost transfer of 23,169 ordinary shares from a closely associated person to Non-executive Director Laure Duhot on January 22, 2026, outside of a trading venue. This transaction, involving ordinary shares with a nominal value of 12.5p, represents an initial notification filed with the FCA in accordance with market abuse regulations.

Disclaimer*

Primary Health Properties PLC

26 January 2026

Primary Health Properties PLC

("PHP" or the "Company"),

Director/PDMR Shareholding

The Company has been notified that the following information relating to the transaction detailed below has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation.

1	Details of person discharging managerial responsibilities/person closely associated
(a)	Name	Laure Duhot
2	Reason for notification
(a)	Position/Status	Non-executive Director
(b)	Initial notification/amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)	Name	Primary Health Properties PLC
(b)	LEI	213800Y5CJHXOATK7X11
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)	Description of the financial instrument	Ordinary shares of 12.5p ISIN: GB00BYRJ5J14
(b)	Nature of the transaction	Nil cost transfer of shares from PCA to Laure Duhot
(c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	23,169
(d)	Aggregated volume Price	23,169 Nil
(e)	Date of transaction	22 January 2026
(f)	Place of transaction	Outside of a trading venue

For further information

Primary Health Properties PLC

Toby Newman, Company Secretary & Chief Legal Officer

+44(0) 7729 047 959

Legal Entity Identifier: 213800Y5CJHXOATK7X11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END